Blood and Lymphatic Cancer: Targets and Therapy

Código QR

Blood and Lymphatic Cancer: Targets and Therapy

Guardado en:

Detalles Bibliográficos
Formato:	journal
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	lymphoma anticancer agents haematology leukaemia Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/toc/1179-9889
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A new era in blood and lymphatic cancer biology and therapy
por: David Dingli
Publicado: (2011)

TARGETED THERAPY IN AML TREATMENT
por: Giovanni Martinelli
Publicado: (2021)

Immune targeted therapy for diffuse large B cell lymphoma
por: Yaxin Zheng, et al.
Publicado: (2021)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Natali Pflug, et al.
Publicado: (2021)

NECESSITY FOR A CUSTOMIZED NGS PANEL FOR ACCURATE DIAGNOSIS AND TARGETED THERAPIES IN PEDIATRIC GLIAL TUMORS
por: Ayça Erşen Danyeli, et al.
Publicado: (2021)

SYNTHETIC BIOLOGY MEETS PRECISION MEDICINE: DRUG REPURPOSING FOR BLOOD CANCER PRECISION MEDICINE
por: Deepak Balaji Thimiri Govindaraj Thimiri Govindaraj
Publicado: (2021)

Emerging targets in human lymphoma: targeting the MYD88 mutation
por: Wang JQ, et al.
Publicado: (2013)

EVALUATION OF THE RELATIONSHIP OF ABO BLOOD GROUPS WITH MIS-C
por: Fatma Burçin KURTİPEK, et al.
Publicado: (2021)

DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?
por: Fatma YILMAZ, et al.
Publicado: (2021)

A rare case of mistaken identity - Historical blood group saved the situation
por: Anand Deshpande, et al.
Publicado: (2021)

MYC as therapeutic target in leukemia and lymphoma
por: Cortiguera MG, et al.
Publicado: (2015)

IL-15 as a potential target in leukemia
por: Xiong Y, et al.
Publicado: (2015)

Targeting CD20 in chronic lymphocytic leukemia
por: Nahas MR, et al.
Publicado: (2015)

INTRAPLEURAL THERAPY TO DRIVE SYSTEMIC ANTI-TUMOR IMMUNITY
por: Vera S. Donnenberg, PhD, FCP, et al.
Publicado: (2021)

Summary of Joint European Hematology Association (EHA) and EuroBloodNet Recommendations on Diagnosis and Treatment of Methemoglobinemia
por: Achille Iolascon, et al.
Publicado: (2021)

COMPARABLE OUTCOMES OF ALLOGENEIC PERIPHERAL BLOOD VERSUS BONE MARROW HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN
por: AYÇA KOCA YOZGAT, et al.
Publicado: (2021)

HEMATOLOGICAL FINDINGS IN COVID-19 AND INSIGHTS TO STEM CELL THERAPY
por: Ghada ELGohary
Publicado: (2021)

Daratumumab improves the anti-myeloma effect of newly emerging multidrug therapies
por: Gopalakrishnan S, et al.
Publicado: (2013)

Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase
por: Farina F, et al.
Publicado: (2014)

First-line therapy of chronic myeloid leukemia &ndash; focus on dasatinib
por: Amrein PC
Publicado: (2012)

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors
por: Vijeta Bajpai, et al.
Publicado: (2021)

INFLAMMATION AND CANCER
por: Jean-François Rossi
Publicado: (2021)

HSP70 and FLT3-ITD: Targeting chaperone system to overcome drug resistance
por: Jing Yang, et al.
Publicado: (2021)

AN APPROACH TO PAIN IN CHILDREN WITH CANCER
por: Yavuz Akçaboy
Publicado: (2021)

PRINCIPLES OF TRANSFUSION IN CHILDREN WITH CANCER
por: Dilek Gürlek Gökçebay
Publicado: (2021)

LATE EFFECTS OF CHILDHOOD CANCER: THE FOUNDATION FOR RISK-STRATIFIED PEDIATRIC CANCER CARE LONG TERM
por: Melissa M. Hudson
Publicado: (2021)

VENETOCLAX AZACITIDINE COMBINATION THERAPY IN FIRST-LINE TREATMENT OF ACUTE MYELOID LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE
por: Melda Cömert, et al.
Publicado: (2021)

LEWIS C IN BREAST CANCER PROGRESSION
por: Нина Гадецкая
Publicado: (2021)

CONCOMITANT JAK2 AND BCR-ABL1 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA CLINICAL IMPACT AND RESPONSE TO THERAPY: A SYSTEMATIC REVIEW
por: Elrazi Ali, et al.
Publicado: (2021)

ANTI-GLYCAN ANTIBODIES IN THE DIAGNOSIS OF GASTRIC CANCER
por: Nadezhda Shilova, et al.
Publicado: (2021)

Bone marrow involvement in small cell lung cancer
por: Giuseppe G. Loscocco, et al.
Publicado: (2021)

PREDICTORS OF OUTCOME AND SURVIVAL IN PROSTATE CANCER – DATA FROM TERTIARY CARE UROLOGY INSTITUTE IN PAKISTAN
por: Syed Najeeb Niamatullah
Publicado: (2021)

THE ROLE OF SUBPOPULATIONS OF MOBILIZED PERIPHERAL HEMATOPOIETIC STEM CELLS IN THE RESTORATION OF HEMATOPOIESIS DURING HIGH-DOSE CHEMOTHERAPY IN CANCER PATIENTS
por: Liudmila GRIVTSOVA, et al.
Publicado: (2021)

B1-CELLS OF INNATE IMMUNITY IN THE BONE MARROW IN BREAST CANCER PATIENTS: IDENTIFICATION AND THEIR RELATIONSHIP WITH CLINICAL AND MORPHOLOGICAL PARAMETERS
por: Svetlana Chulkova, et al.
Publicado: (2021)

Uptake of lymphoma-derived exosomes by peripheral blood leukocytes
por: Ferguson Bennit HR, et al.
Publicado: (2017)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
por: Zhang CL, et al.
Publicado: (2012)

Peripheral T cell lymphoma: clinical utility of romidepsin
por: Sawey K, et al.
Publicado: (2012)

The evaluation and optimal use of rituximab in lymphoid malignancies
por: Smolewski P, et al.
Publicado: (2012)

Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future
por: Flowers CR, et al.
Publicado: (2012)

Recent developments in myelofibrosis
por: Mesa RA, et al.
Publicado: (2012)